Archives
Traumatic brain injuries are common, often devastating, and, for many, poorly responsive to treatment. While methods to evaluate TBI advanced substantially during recent decades and principles of supportive care have also progressed, there are no pharmacologic therapies that seek to specifically stimulate neurogenesis (growth of new neurons) or synaptogenesis during the post-acute phase of care.
Present: Sudhir Agrawal, Mark Bear, Graham Dempsey, Alan Kopin, Hal Lewis, David Margulies, Stephen Strittmatter
Unable to attend: Kevin Eggan, David Meaney
Present: David Margulies (Moderator), Hal Lewis, David Meaney, Mark Bear, Sudhir Agrawal, Stephen Strittmatter, Alan Kopin, Graham Dempsey, Kevin Eggan, Michael Crair
A meeting of the Dan Lewis Foundation for Brain Regeneration Research was held via Zoom Conference on Thursday, June 11th, 2020 from 11:00 a.m. to 4:00 p.m. EST. The primary purposes of this meeting were to promote collaboration between leading scientists in the area of cortical regeneration and to begin planning a research agenda to accomplish the mission of the Foundation. That mission—to identify new biomedical approaches that promote neural regeneration, axonal growth, and synaptogenesis to improve the lives of persons with moderate and severe traumatic brain injuries and their families—was affirmed by group consensus.
Your support can make a difference
Please consider donating. Every dollar donated goes toward keeping our research alive.
The Dan Lewis Foundation for Brain Regeneration Research is an incorporated 501(c)(3) non-profit organization. Donations are tax deductible.
Thank you to our sponsors: Google for Non-Profits
Donations of stock may have significant tax benefits for the donor and are a great way to support the foundation. Please contact us for more information regarding the tax benefits and the process of transferring stock to the foundation.